Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China

American Journal of Drug and Alcohol Abuse

Volumn 38, Issue 3, 2012, Pages 228-232

  Du, Jiang ^a   Wang, Zhen ^a   Xie, Bin ^a   Zhao, Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alcohol; Hepatitis C; Heroin users; Methadone maintenance treatment

Indexed keywords

METHADONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AWARENESS; CHINA; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; DRUG DEPENDENCE TREATMENT; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; INFECTION RISK; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; SUBSTANCE ABUSE; VIRUS HEPATITIS;

ADULT; ALCOHOL DRINKING; ANTIVIRAL AGENTS; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HUMANS; MAINTENANCE CHEMOTHERAPY; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; VIRAL LOAD;

EID: 84859731266     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2011.643974     Document Type: Article

References (17)

1. WHO. Hepatitis C: Global prevalence (update). Wkly Epidemiol Rec 2000; 75(3):18-19.
2. Wang H. Epidemiology of Hepatitis C virus and prevention. China J Hopatol 2003; 11(6):366-368. Available at: http://www.chinesefms.com/doc/gb/doc-gb- zjft/200911/t20091123-40061.html. Last accessed on December 22, 2011.
3. Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis. J Public Health 2008; 122(10):990-1003.
4. Srivastava A, Kahan M, Ross S. The effect of methadone maintenance treatment on alcohol consumption: A systematic review. J Subst Abuse Treat 2008; 34(2):215-223.
5. O'Brien S, Day C, Black E, Dolan K. Injecting drug users' understanding of hepatitis C. J Addict Behav 2008; 33(12):1602-1605.
6. Babor TF, John C, Saunders JB, Maristela G. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. (2nd ed.). Geneva: World Health Organization/MSD/MSB, 2001.
7. Li B, Yuchun S, Boquan Z, Xiaohua Z, Xiaoguang Z. The test of audit in China. Chin Ment Health J 2003; 17(1):22-24.
8. Guo W, Lanzi G, Luobu O, Ma X, Zhen P, Ji Y, Wei G, Wang Z, Deng W, Zhuoma B, Wang Y, Shi X, Yan C, Liu X, Collier DA, Ball D, Li T. An epidemiological survey of alcohol use disorders in a Tibetan population. Psychiatry Res 2008; 159(12):56-66.
9. Strauss SM, Astone-Twerell JM, Munoz-Plaza C, Des Jarlais DC, Gwadz M, Hagan H, Osborne A, Rosenblum A. Hepatitis C knowledge among staff in U.S. drug treatment programs. J Drug Educ 2006; 36(2): 141-58.
10. Chetwynd J, Brunton C, Blank M, Plumridge E, Baldwin D. Hepatitis C seroprevalence amongst injecting drug users attending a methadone program. NZ Med J 1995; 108(1007):364-366.
11. Strauss SM, Astone-Twerell J, Munoz-Plaza C. Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res 2007; 7:39.
12. NIH consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Statements 2002; 19:1-46.
13. Chinese Society of Hepatology. Hepatitis C prevention guideline in China. Chin J Hepatol 2004; 12(2):194-198.
14. Xiaojuan L, Shujie F, Rui Z. Alcohol abuse on the patients with methadone maintain treatment. Chin J Drug Abuse Prev Treat 2008; 14(4):205-208.
15. Macmanus E, Fitzpatrick C. Alcohol dependence and mood state in a population receiving methadone maintenance treatment. Ir J Psychol Med 2007; 24(1):19-22.
16. Laine C, Hauck WW, Gourevitch MN, Rothman J, Cohen A, Turner BJ. Regular outpatient medical and drug abuse care and subsequent hospitalizations of persons who use illicit drugs. J Am Med Assoc 2001; 285(18):2355-2362.
17. Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: A randomized controlled trial. J Am Med Assoc 2001; 286(14):1715-1723.